67 related articles for article (PubMed ID: 22176624)
1. Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines.
Kim S; Yun YM; Chae HJ; Cho HJ; Ji M; Kim IS; Wee KA; Lee W; Song SH; Woo HI; Lee SY; Chun S
Ann Lab Med; 2017 Mar; 37(2):180-193. PubMed ID: 28029011
[TBL] [Abstract][Full Text] [Related]
2. Ocular Drug-Metabolizing Enzymes: Focus on Esterases.
Hammid A; Honkakoski P
Drug Metab Rev; 2024 Jun; ():1-23. PubMed ID: 38888291
[No Abstract] [Full Text] [Related]
3. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.
Sim SC; Kacevska M; Ingelman-Sundberg M
Pharmacogenomics J; 2013 Feb; 13(1):1-11. PubMed ID: 23089672
[TBL] [Abstract][Full Text] [Related]
4. Outpatient Pharmacogenomic Screenings to Prevent Addiction, Overdose, and Suicide.
Yarlagadda A; Swift K; Chakraborty N; Hammamieh R; Abubakar A; Wilbur M; Clayton AH
Innov Clin Neurosci; 2023; 20(10-12):12-17. PubMed ID: 38193100
[TBL] [Abstract][Full Text] [Related]
5. Lack of association of CYP2B6 pharmacogenetics with cyclophosphamide toxicity in patients with cancer.
Hwang M; Medley S; Shakeel F; Vanderwerff B; Zawistowski M; Kidwell KM; Hertz DL
Support Care Cancer; 2022 Sep; 30(9):7355-7363. PubMed ID: 35606478
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort.
Dodgen TM; Labuschagne CJ; van Schalkwyk A; Steffens FE; Gaedigk A; Cromarty AD; Alessandrini M; Pepper MS
Pharmacogenomics J; 2016 Nov; 16(6):566-572. PubMed ID: 26503815
[TBL] [Abstract][Full Text] [Related]
7. Systematic functional study of cytochrome P450 2D6 promoter polymorphisms in the Chinese Han population.
Gong X; Liu Y; Zhang X; Wei Z; Huo R; Shen L; He L; Qin S
PLoS One; 2013; 8(2):e57764. PubMed ID: 23469064
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of genetic variation and transcriptional regulation of CYP2C19.
Helsby NA; Burns KE
Front Genet; 2012; 3():206. PubMed ID: 23087703
[TBL] [Abstract][Full Text] [Related]
9. [Individualization of drug therapy and pharmacogenetics].
Yamamoto I; Azuma J
Nihon Rinsho; 1998 Mar; 56(3):579-83. PubMed ID: 9549339
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of drug-metabolizing enzymes: the prodrug hypothesis.
Begg EJ; Helsby NA; Jensen BP
Pharmacogenomics; 2012 Jan; 13(1):83-9. PubMed ID: 22176624
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacogenetics and potential application in personalized medicine.
Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
[TBL] [Abstract][Full Text] [Related]
12. Clinical applicability of sequence variations in genes related to drug metabolism.
Stojiljkovic M; Patrinos GP; Pavlovic S
Curr Drug Metab; 2011 Jun; 12(5):445-54. PubMed ID: 21453274
[TBL] [Abstract][Full Text] [Related]
13. Clinical interest of point-of-care pharmacogenomic testing: clopidogrel behind warfarin.
Shahabi P; Siest G; Visvikis-Siest S
Pharmacogenomics; 2012 Aug; 13(11):1215-8. PubMed ID: 22920390
[No Abstract] [Full Text] [Related]
14. Clinical pharmacogenomics of warfarin and clopidogrel.
Shin J
J Pharm Pract; 2012 Aug; 25(4):428-38. PubMed ID: 22674970
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
